Sector | Chemicals | Compare with Sector peers |
Industry | Chemicals | Compare with Industry peers |
Website | http://www.spandiag.com | |
Market Cap | 9.34 Cr. | |
Enterprise Value(EV) | 18.75 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -6.32 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 44.62 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | -5.39 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | -3.17 | Calculated using Price: 17.10 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.55 Cr. | 5,461,747 Shares |
FaceValue | 10 | |
About Span Divergent Ltd. | ||
A thought, conceived more than three decades ago by a pathologist, Dr. Pradip K. Desai, evolved into a start-up company as the Desai Laboratories. The goal was to indigenously develop and manufacture a comprehensive range of ready-made diagnostic reagents needed by clinical pathology laboratories. In 1976, the company was reorganized as Span Diagnostics with an emphasis on in-house R & D to develop more and more products, keeping the customer needs in focus and quality under constant vigil. |
1 Day |
|
-4.95% |
1 Week |
|
+5.10% |
1 Month |
|
+14.69% |
3 Month |
|
+16.33% |
6 Month |
|
+32.56% |
1 Year |
|
+41.32% |
2 Year |
|
+36.25% |
5 Year |
|
-32.94% |
10 Year |
|
-55.29% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 92.48 | 5.87 | -5.29 | -29.53 | -45.78 | -40.14 | -41.61 | -142.6 | 0 | |
Return on Capital Employed (%) | 80.49 | 8.14 | -4.08 | -17.56 | -21.68 | -17.85 | -14.67 | -44.86 | -43.9 | |
Return on Assets (%) | 50.2 | 5.63 | -4.53 | -19.54 | -24.98 | -19.44 | -16.73 | -32.78 | -20.51 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 62 | 50 | 49 | 36 | 25 | 18 | 12 | 2 | -3 | -3 | |
Non Curr. Liab. | 0 | 0 | 7 | 9 | 8 | 11 | 13 | 7 | 6 | 5 | |
Curr. Liab. | 4 | 0 | 9 | 18 | 19 | 15 | 14 | 23 | 28 | 28 | |
Minority Int. | 0 | 0 | -3 | -4 | -5 | -5 | -6 | -6 | |||
Equity & Liab. | 66 | 51 | 65 | 63 | 49 | 39 | 34 | 28 | 25 | 24 | |
Non Curr. Assets | 12 | 13 | 28 | 27 | 24 | 21 | 18 | 16 | 14 | 12 | |
Curr. Assets | 54 | 38 | 37 | 36 | 25 | 18 | 16 | 12 | 12 | 12 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 66 | 51 | 65 | 63 | 49 | 39 | 34 | 28 | 25 | 24 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 76 | 3 | 15 | 24 | 9 | 7 | 13 | 13 | 13 | ||
Other Income | 2 | 3 | 4 | 3 | 1 | 2 | 2 | 3 | 1 | 1 | |
Total Income | 78 | 3 | 7 | 18 | 25 | 12 | 9 | 16 | 13 | 14 | |
Total Expenditure | -74 | -5 | -8 | -25 | -31 | -15 | -10 | -14 | -11 | -12 | |
PBIDT | 3 | -3 | -1 | -7 | -6 | -3 | 0 | 2 | 2 | 2 | |
Interest | -4 | 0 | 0 | -2 | -2 | -2 | -2 | -1 | -1 | -1 | |
Depreciation | -6 | 0 | -1 | -3 | -4 | -3 | -3 | -2 | -2 | -2 | |
Taxation | -6 | -1 | 0 | 0 | -1 | 1 | 0 | 0 | 0 | 0 | |
Exceptional Items | 52 | 7 | -1 | -2 | -1 | -1 | -9 | -4 | -3 | ||
PAT | 39 | 3 | -3 | -13 | -14 | -9 | -6 | -10 | -5 | -4 | |
Minority Interest | 0 | 2 | 1 | 1 | 0 | 0 | 0 | ||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 39 | 3 | -3 | -13 | -12 | -8 | -6 | -10 | -5 | -3 | |
Adjusted EPS | 54 | 6 | -5 | -23 | -22 | -14 | -10 | -18 | -9 | -6 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 8 | 61 | -7 | -5 | -12 | -7 | 0 | 0 | 7 | 2 | |
Cash Fr. Inv. | -5 | -12 | 13 | -6 | 1 | 10 | 6 | 2 | -2 | 1 | |
Cash Fr. Finan. | -4 | -42 | -12 | 13 | 7 | -3 | -7 | -1 | -6 | -2 | |
Net Change | 0 | 7 | -6 | 2 | -4 | 0 | -2 | 0 | -1 | 0 | |
Cash & Cash Eqvt | 1 | 8 | 2 | 5 | 2 | 2 | 0 | 1 | 0 | 0 |
Tue, 26 Mar 2024
Closure of Trading Window Span Divergent Limited - Intimation regarding closure of trading window |
Fri, 15 Mar 2024
Span Divergent Limited - Update - Completion Of Sale Of Immovable Property Span Divergent Limited - Update - Completion of Sale of Immovable Property |
Wed, 14 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Span Divergent Limited - Newspaper publications |
Thu, 28 Mar 2024 |
High Delivery Percentage |
Opening at High |
Opening at Low |
Closing Below Previous Low |
Close Within 52 Week High Zone |